lHCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality
<p>Abstract</p> <p>Background</p> <p>Hepatitis C virus (HCV) is a leading cause of chronic liver disease, end-stage cirrhosis, and liver cancer, but little is known about the burden of disease caused by the virus. We summarised burden of disease data presently available...
Saved in:
Main Authors: | Siebert Uwe (Author), Zeuzem Stefan (Author), Sroczynski Gaby (Author), Lettmeier Beate (Author), Schwarzer Ruth (Author), Mühlberger Nikolai (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2009-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model
by: Nikolai Mühlberger, et al.
Published: (2017) -
Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment
by: Carine Raquel Blatt, et al.
Published: (2014) -
HCV treatment in children and young adults with HIV/HCV co-infection in Europe
by: Anna Turkova, et al.
Published: (2015) -
Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia
by: Vukićević Đurđa, et al.
Published: (2020) -
Burden of intracerebral haemorrhage in Europe: forecasting incidence and mortality between 2019 and 2050Research in context
by: Hatem A. Wafa, et al.
Published: (2024)